|
1
|
Tria FP IV, Ang DC and Fan G:
Myelodysplastic syndrome: Diagnosis and screening. Diagnostics
(Basel). 12(1581)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Garcia-Manero G, Chien KS and
Montalban-Bravo G: Myelodysplastic syndromes: 2021 Update on
diagnosis, risk stratification and management. Am J Hematol.
95:1399–1420. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Luskin MR and Abel GA: Management of older
adults with myelodysplastic syndromes (MDS). J Geriatr Oncol.
9:302–307. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Abel GA, Kim HT, Hantel A, Steensma DP,
Stone R, Habib A, Ho VT, Wadleigh M, El-Jawahri A, Alyea EP, et al:
Fit older adults with advanced myelodysplastic syndromes: Who is
most likely to benefit from transplant? Leukemia. 35:1166–1175.
2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gupta G, Singh R, Kotasthane DS and
Kotasthane VD: Myelodysplastic syndromes/neoplasms: Recent
classification system based on World Health Organization
classification of tumors-international agency for research on
cancer for hematopoietic and lymphoid tissues. J Blood Med.
1:171–182. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Dayyani F, Conley AP, Strom SS, Stevenson
W, Cortes JE, Borthakur G, Faderl S, O'Brien S, Pierce S,
Kantarjian H and Garcia-Manero G: Cause of death in patients with
lower-risk myelodysplastic syndrome. Cancer. 116:2174–2179.
2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Raza A, Gezer S, Mundle S, Gao XZ, Alvi S,
Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A, et al:
Apoptosis in bone marrow biopsy samples involving stromal and
hematopoietic cells in 50 patients with myelodysplastic syndromes.
Blood. 86:268–276. 1995.PubMed/NCBI
|
|
8
|
Gañán-Gómez I, Wei Y, Starczynowski DT,
Colla S, Yang H, Cabrero-Calvo M, Bohannan ZS, Verma A, Steidl U
and Garcia-Manero G: Deregulation of innate immune and inflammatory
signaling in myelodysplastic syndromes. Leukemia. 29:1458–1469.
2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Papaemmanuil E, Gerstung M, Malcovati L,
Tauro S, Gundem G, Van Loo P, Yoon CJ, Ellis P, Wedge DC,
Pellagatti A, et al: Clinical and biological implications of driver
mutations in myelodysplastic syndromes. Blood. 122:3616–3627, 3699.
2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sekeres MA and Taylor J: Diagnosis and
treatment of myelodysplastic syndromes: A review. JAMA.
328:872–880. 2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Greenberg P, Cox C, LeBeau MM, Fenaux P,
Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, et al:
International scoring system for evaluating prognosis in
myelodysplastic syndromes. Blood. 89:2079–2088. 1997.PubMed/NCBI
|
|
12
|
Greenberg PL, Tuechler H, Schanz J, Sanz
G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus
F, et al: Revised international prognostic scoring system for
myelodysplastic syndromes. Blood. 120:2454–2465. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Scalzulli E, Pepe S, Colafigli G and
Breccia M: Therapeutic strategies in low and high-risk MDS: What
does the future have to offer? Blood Rev. 45(100689)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Vardiman JW, Harris NL and Brunning RD:
The World Health Organization (WHO) classification of the myeloid
neoplasms. Blood. 100:2292–2302. 2002.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wlodarski MW, Sahoo SS and Niemeyer CM:
Monosomy 7 in pediatric myelodysplastic syndromes. Hematol Oncol
Clin North Am. 32:729–743. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Schratz KE and DeZern AE: Genetic
predisposition to myelodysplastic syndrome in clinical practice.
Hematol Oncol Clin North Am. 34:333–356. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kennedy AL and Shimamura A: Genetic
predisposition to MDS: Clinical features and clonal evolution.
Blood. 133:1071–1085. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cabello-Verrugio C, Simon F, Trollet C and
Santibañez JF: Oxidative stress in disease and aging: Mechanisms
and therapies 2016. Oxid Med Cell Longev.
2017(4310469)2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sies H, Berndt C and Jones DP: Oxidative
stress. Annu Rev Biochem. 86:715–748. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Montes P, Guerra-Librero A, García P,
Cornejo-Calvo ME, López MDS, Haro T, Martínez-Ruiz L, Escames G and
Acuña-Castroviejo D: Effect of 5-azacitidine treatment on redox
status and inflammatory condition in MDS patients. Antioxidants
(Basel). 11(139)2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Imbesi S, Musolino C, Allegra A, Saija A,
Morabito F, Calapai G and Gangemi S: Oxidative stress in
oncohematologic diseases: An update. Expert Rev Hematol. 6:317–325.
2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tsamesidis I, Pantaleo A, Pekou A, Gusani
A, Iliadis S, Makedou K, Manca A, Carruale A, Lymperaki E and Fozza
C: Correlation of oxidative stress biomarkers and hematological
parameters in blood cancer patients from Sardinia, Italy. Int J
Hematol Oncol Stem Cell Res. 13:49–57. 2019.PubMed/NCBI
|
|
23
|
Nikitovic D, Corsini E, Kouretas D,
Tsatsakis A and Tzanakakis G: ROS-major mediators of extracellular
matrix remodeling during tumor progression. Food Chem Toxicol.
61:178–186. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Finkel T and Holbrook NJ: Oxidants,
oxidative stress and the biology of ageing. Nature. 408:239–247.
2000.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ghoti H, Amer J, Winder A, Rachmilewitz E
and Fibach E: Oxidative stress in red blood cells, platelets and
polymorphonuclear leukocytes from patients with myelodysplastic
syndrome. Eur J Haematol. 79:463–467. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Picou F, Vignon C, Debeissat C, Lachot S,
Kosmider O, Gallay N, Foucault A, Estienne MH, Ravalet N, Bene MC,
et al: Bone marrow oxidative stress and specific antioxidant
signatures in myelodysplastic syndromes. Blood Adv. 3:4271–4279.
2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kim CH and Leitch HA: Iron
overload-induced oxidative stress in myelodysplastic syndromes and
its cellular sequelae. Crit Rev Oncol Hematol.
163(103367)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jing Q, Zhou C, Zhang J, Zhang P, Wu Y,
Zhou J, Tong X, Li Y, Du J and Wang Y: Role of reactive oxygen
species in myelodysplastic syndromes. Cell Mol Biol Lett.
29(53)2024.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hong M and He G: The 2016 revision to the
World Health Organization classification of myelodysplastic
syndromes. J Transl Int Med. 5:139–143. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Reddy YN, Murthy SV, Krishna DR and
Prabhakar MC: Role of free radicals and antioxidants in
tuberculosis patients. Indian J Tuberc. 51:213–218. 2004.
|
|
31
|
Veskoukis AS, Kyparos A, Paschalis V and
Nikolaidis MG: Spectrophotometric assays for measuring redox
biomarkers in blood. Biomarkers. 21:208–217. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Janaszewska A and Bartosz G: Assay of
total antioxidant capacity: Comparison of four methods as applied
to human blood plasma. Scand J Clin Lab Invest. 62:231–236.
2002.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Spanidis Y, Goutzourelas N, Stagos D,
Mpesios A, Priftis A, Bar-Or D, Spandidos DA, Tsatsakis AM, Leon G
and Kouretas D: Variations in oxidative stress markers in elite
basketball players at the beginning and end of a season. Exp Ther
Med. 11:147–153. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hasserjian RP: Myelodysplastic syndrome
updated. Pathobiology. 86:7–13. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Farquhar MJ and Bowen DT: Oxidative stress
and the myelodysplastic syndromes. Int J Hematol. 77:342–350.
2003.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Avgerinou C, Alamanos Y, Kouraklis A,
Tavernarakis I, Zikos P, Aktypi A, Kaiafas P, Raptis C, Karakantza
M, Zoumbos N and Symeonidis A: Epidemiology of myelodysplastic
syndromes in the area of Southwestern Greece during the period
1990-2009. Achaiki Iatriki. 30:105–124. 2011.
|
|
37
|
Vunjak-Novakovic G, Tandon N, Godier A,
Maidhof R, Marsano A, Martens TP and Radisic M: Challenges in
cardiac tissue engineering. Tissue Eng Part B Rev. 16:169–187.
2009.
|
|
38
|
Travlos GS: Normal structure, function,
and histology of the bone marrow. Toxicol Pathol. 34:548–565.
2006.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kuhn V, Diederich L, Keller TCS IV, Kramer
CM, Lückstädt W, Panknin C, Suvorava T, Isakson BE, Kelm M and
Cortese-Krott MM: Red blood cell function and dysfunction: Redox
regulation, nitric oxide metabolism, anemia. Antioxid Redox Signal.
26:718–742. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Visconte V, Tiu RV and Rogers HJ:
Pathogenesis of myelodysplastic syndromes: An overview of molecular
and non-molecular aspects of the disease. Blood Res. 49:216–227.
2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Cui H, Kong Y and Zhang H: Oxidative
stress, mitochondrial dysfunction, and aging. J Signal Transduct.
2012(646354)2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Gupta M, Madkaikar M, Rao VB, Mishra A,
Govindaraj P, Thangaraj K and Ghosh K: Mitochondrial DNA variations
in myelodysplastic syndrome. Ann Hematol. 92:871–876.
2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Filanovsky K, Haran M, Mirkin V, Braester
A, Shvetz O, Stanevsky A, Sigler E, Votinov E, Zaltsman-Amir Y,
Gross A and Shvidel L: Clinical benefit and improvement of
mitochondrial function in low risk myelodysplastic syndrome treated
by combination ultra coenzyme Q10 and L-carnitine. Blood. 130
(Suppl 1)(S1704)2017.
|
|
44
|
Sen T, Jain M, Gram M, Mattebo A, Soneji
S, Walkley CR and Singbrant S: Enhancing mitochondrial function in
vivo rescues MDS-like anemia induced by pRb deficiency. Exp
Hematol. 88:28–41. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Hlaváčková A, Štikarová J, Pimková K,
Chrastinová L, Májek P, Kotlín R, Čermák J, Suttnar J and Dyr JE:
Enhanced plasma protein carbonylation in patients with
myelodysplastic syndromes. Free Radic Biol Med. 108:1–7.
2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
de Souza GF, Barbosa MC, de Jesus Santos
TE, Carvalho TM, de Freitas RM, Martins MR, Gonçalves RP, Pinheiro
RF and Magalhães SM: Increased parameters of oxidative stress and
its relation to transfusion iron overload in patients with
myelodysplastic syndromes. J Clin Pathol. 66:996–998.
2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Veskoukis A, Kerasioti E, Priftis A, Kouka
P, Spanidis Y, Makri S and Kouretas D: A battery of translational
biomarkers for the assessment of the in vitro and in vivo
antioxidant action of plant polyphenolic compounds: The biomarker
issue. Curr Opin Toxicol. 13:99–109. 2019.
|
|
48
|
Carvalho AN, Lim JL, Nijland PG, Witte ME
and Van Horssen J: Glutathione in multiple sclerosis: More than
just an antioxidant? Mult Scler. 20:1425–1431. 2014.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Mylonas C and Kouretas D: Lipid
peroxidation and tissue damage. In Vivo. 13:295–309.
1999.PubMed/NCBI
|
|
50
|
Saigo K, Takenokuchi M, Hiramatsu Y, Tada
H, Hishita T, Takata M, Misawa M, Imoto S and Imashuku S: Oxidative
stress levels in myelodysplastic syndrome patients: Their
relationship to serum ferritin and haemoglobin values. J Int Med
Res. 39:1941–1945. 2011.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Gonçalves AC, Alves R, Baldeiras I, Jorge
J, Marques B, Paiva A, Oliveiros B, Cortesão E, Nascimento Costa JM
and Sarmento-Ribeiro AB: Oxidative stress parameters can predict
the response to erythropoiesis-stimulating agents in
myelodysplastic syndrome patients. Front Cell Dev Biol.
9(701328)2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Kaweme NM, Zhou S, Changwe GJ and Zhou F:
The significant role of redox system in myeloid leukemia: From
pathogenesis to therapeutic applications. Biomark Res.
8(63)2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Čipak Gašparović A: Free radical research
in cancer. Antioxidants (Basel). 9(157)2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Gonçalves AC, Cortesão E, Oliveiros B,
Alves V, Espadana AI, Rito L, Magalhães E, Lobão MJ, Pereira A,
Nascimento Costa JM, et al: Oxidative stress and mitochondrial
dysfunction play a role in myelodysplastic syndrome development,
diagnosis, and prognosis: A pilot study. Free Radic Res.
49:1081–1094. 2015.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Makri S, Kafantaris I, Stagos D,
Chamokeridou T, Petrotos K, Gerasopoulos K, Mpesios A, Goutzourelas
N, Kokkas S, Goulas P, et al: Novel feed including bioactive
compounds from winery wastes improved broilers' redox status in
blood and tissues of vital organs. Food Chem Toxicol. 102:24–31.
2017.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Bartosz G: Total antioxidant capacity. Adv
Clin Chem. 37:219–292. 2003.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Lyle L and Hirose A: Iron overload in
myelodysplastic syndromes: Pathophysiology, consequences,
diagnosis, and treatment. J Adv Pract Oncol. 9:392–405.
2018.PubMed/NCBI
|
|
58
|
Skenderidis P, Kerasioti E, Karkanta E,
Stagos D, Kouretas D, Petrotos K, Hadjichristodoulou C and Tsakalof
A: Assessment of the antioxidant and antimutagenic activity of
extracts from goji berry of Greek cultivation. Toxicol Rep.
5:251–257. 2018.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Nepka C, Sivridis E, Antonoglou O,
Kortsaris A, Georgellis A, Taitzoglou I, Hytiroglou P,
Papadimitriou C, Zintzaras I and Kouretas D: Chemopreventive
activity of very low dose dietary tannic acid administration in
hepatoma bearing C3H male mice. Cancer Lett. 141:57–62.
1999.PubMed/NCBI View Article : Google Scholar
|
